Tag:
CYT006-AngQb
Latest Headlines
Latest Headlines
Cytos slashes staff after vaccine fails key trial
Shares of Switzerland's Cytos Biotechnology tanked after the developer said its high blood pressure vaccine failed a mid-stage trial. Cytos now says it will hand out pink slips to 42 percent of its
